Meilan He
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
-
- Viral-associated cancers and disorders
Papers in
-
- Genomics, phytochemicals, and oxidative stress 2
- Oncology 9
- Viral-associated cancers and disorders 9
- Co-authors
- Shou‐Jiang Gao (9 shared papers)Jae U. Jung (3 shared papers)Charles Y.F. Young (4 shared papers)Fengchun Ye (2 shared papers)Chun Lu (3 shared papers)Suzane Ramos da Silva (3 shared papers)Fan Cheng (3 shared papers)Donkena Krishna Vanaja (3 shared papers)
- Journals
- Acta Pharmacologica Sinica (3 papers)Journal of Virology (2 papers)Acta Biochimica et Biophysica Sinica (2 papers)Oncotarget (2 papers)PLoS Pathogens (2 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Meilan He
27 papers receiving 625 citations
Peers
Comparison fields: 5 of 78
- Geriatrics and Gerontology 47
- Oncology 195
- Epidemiology 196
- Physiology 28
- Cancer Research 70
Countries citing papers authored by Meilan He
This map shows the geographic impact of Meilan He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meilan He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meilan He more than expected).
Fields of papers citing papers by Meilan He
This network shows the impact of papers produced by Meilan He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meilan He. The network helps show where Meilan He may publish in the future.
Co-authors
The 25 scholars most cited alongside Meilan He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 66 | |
| 2 | 2012 | 64 | |
| 3 | 2016 | 58 | |
| 4 | 2009 | 45 | |
| 5 | 2007 | 42 | |
| 6 | 2017 | 40 | |
| 7 | 2012 | 37 | |
| 8 | 2016 | 33 | |
| 9 | 2008 | 24 | |
| 10 | 2008 | 24 | |
| 11 | 2017 | 23 | |
| 12 | 2006 | 20 | |
| 13 | 2014 | 16 | |
| 14 | 2007 | 16 | |
| 15 | 2016 | 16 | |
| 16 | 2010 | 15 | |
| 17 | 2011 | 14 | |
| 18 | 2009 | 13 | |
| 19 | 2008 | 12 | |
| 20 | Identification of androgen-responsive element ARE and Sp1 element in the maspin promoter. | 2005 | 11 |
About Meilan He
Meilan He is a scholar working on Molecular Biology, Oncology, Epidemiology, Cancer Research and Surgery, having authored 29 papers that have together received 632 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (9 papers), Cytomegalovirus and herpesvirus research (6 papers), Transportation and Mobility Innovations (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Sirtuins and Resveratrol in Medicine (2 papers), Prostate Cancer Treatment and Research (2 papers), Hair Growth and Disorders (2 papers) and Sharing Economy and Platforms (2 papers). The work is most often cited by research in Geriatrics and Gerontology (47 citations), Oncology (195 citations), Epidemiology (196 citations), Physiology (28 citations) and Cancer Research (70 citations). Meilan He has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Shou‐Jiang Gao, Jae U. Jung, Charles Y.F. Young, Fengchun Ye, Chun Lu, Suzane Ramos da Silva, Fan Cheng, Donkena Krishna Vanaja, Fuchun Zhou and Qiuhua Li. Their work appears in journals such as Acta Pharmacologica Sinica, Journal of Virology, Acta Biochimica et Biophysica Sinica, Oncotarget and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.